Ivospemin
Based on 1 Customer Validation
Ivospemin (SBP-101) is an antineoplastic spermine analog. Ivospemin has shown efficacy in slowing pancreatic and ovarian tumor progression in vitro and in vivo. Ivospemin shows modest induction of polyamine catabolism, but stronger repression of ornithine decarboxylase activity. Ivospemin is promising for research of cancers.
For research use only. We do not sell to patients.
- Purity: 99.89%
- CAS No.: 748119-79-1
- Formula: C16H38N4O2
- Molecular Weight:318.50
-
Storage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
Biological Activity
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| L1210 | IC50 |
0.06 μM
Compound: (S,S)-(HO)2 DEHSPM
|
Growth uM after 96 hours
Growth uM after 96 hours
|
[PMID: 10649978] |
| L1210 | IC50 |
2 μM
Compound: (S,S)-(HO)2 DEHSPM
|
Growth uM after 48 hours
Growth uM after 48 hours
|
[PMID: 10649978] |
Ivospemin (500 nM to 10 µM, 96 h) reduces cell viability in human ovarian adenocarcinoma cells with IC50 values ranging between 0.95 µM and 3.24 µM regardless of cisplatin sensitivity[2].
IC50 values following Ivospemin treatment in human ovarian adenocarcinoma cell lines[1]
| Cell Line | CaOV-3 | A2780 | OV90 | ACRP |
| Ivospemin 96 h IC50 | 2.56 µM | 0.95 µM | 3.24 µM | 1.41 µM |